Navigation Links
EcoHealth Alliance announces new award from USAID to combat disease emergence and climate change
Date:9/23/2013

NEW YORK September 20, 2013 EcoHealth Alliance, a nonprofit organization that focuses on local conservation and global health issues, announced the award of a three-year, $2 million award to address land use alteration as a significant driver of both disease emergence and climate change in Asia. The funding for the new program was awarded by U.S. Agency for International Development, Regional Development Mission for Asia (RDMA).

Over 60 percent of emerging infectious diseases over the past six decadesfrom SARS to pandemic H1N1 and HIVhave originated in animals, with nearly half linked to land use change, agricultural intensification, or changes in food production. Land alterations accelerate the pace and diversity of human and animal contact, enabling pathogens to spill over from animal populations, a first spark in the chain of events that ignite global pandemics. Simultaneously, deforestation and forest degradation resulting from land alterations account for between 14 to 17 percent of greenhouse gas emissions, a rough equivalent to the entire global transportation sector. The key to reducing the threat from diseases of pandemic potential and slowing climate change is a more comprehensive understanding of how functional ecosystems mitigate disease emergence and enhance carbon storage.

In partnership with the Sabah Wildlife Department and University of Malaysia Sabah, EcoHealth Alliance will apply data from the Kinabatangan basin in Sabah, Malaysia to value the infectious disease regulatory role of ecosystems. By capturing value from disease avoidance as a significant component of total ecosystem services valuations, the work is expected to yield actionable, economically sound strategies to promote reduced impact land use policy. "This project will set the agenda for how we can bring together international development, health and environmental programs under one umbrella. By building a partnership with government and the private sector, we will develop solutions that have real traction to reduce carbon emissions, promote a healthier planet, and prevent extinction, while at the same time building sustainable economic growth," commented, Dr. Peter Daszak, President of EcoHealth Alliance, and Chief-of-Party for the IDEEAL program.

The project will launch a Sabah-based Center for Development and Health, serving as a clearinghouse for multi-disciplinary applied research, training, and advocacy. The center will serve a key function in building alliances and engaging industry in designing solutions to these common challenges by hosting regular roundtables that convene stakeholders from across the Malaysian government, civil society, and the private sector. "There is increasing evidence that intact ecosystems are better able to reduce risk of infectious disease spillover events, a function that's an important component of ecosystem services," said Datuk Dr. Laurentius Ambu, Director of the Sabah Wildlife Department. "By placing economic value on this ecosystem service, the project will help strengthen appreciation for maintaining healthy ecosystems, reducing infectious disease spillover events, and will provide the tools needed to guide sustainable land use policies."


'/>"/>

Contact: Anthony M. Ramos
ramos@ecohealthalliance.org
212-380-4469
EcoHealth Alliance
Source:Eurekalert

Related biology news :

1. Iris Biometrics Leader EyeLock Joins the FIDO Alliance to Help Identify More Secure Replacement for Usernames and Passwords
2. New alliance for European excellence and competitiveness in life sciences
3. Core for Life, a new European alliance in biomedical research
4. Viral alliances overcoming plant defenses
5. NSF research alliances begin new efforts to accelerate innovation
6. Phoenix Community Alliance honors TGens Dr. Jeffrey Trent
7. Dolphins cultivate loose alliances
8. NIH announces awards to strengthen the biomedical research workforce
9. New York Genome Center announces the New York Stem Cell Foundation as an Associate Member
10. DiscoveRx Announces Launch of New Human Primary Cell-Based Panels for Oncology Research
11. Entomological Society of America announces 2013 awardees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: